HELP · NASDAQ Global Market

Cybin D/B/A Helus Pharma

WEAK

Momentum score based on proprietary multi-factor analysis

Last updated: Feb 27, 2026, 05:57 AM UTC

How is this calculated? →

Not investment advice. Learn more

Cybin D/B/A Helus Pharma Momentum Score — 33/100